Solu featured in 2 new publications examining food-borne pathogens in the UAE

Validating Solu's phylogeny pipeline with a 2012 Salmonella Bareilly outbreak dataset.

We used Solu Platform to analyze a dataset of 21 Candida auris samples and gained insights into an outbreak.

Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.

Solu’s Candida.app tool enables quick and easy genomic characterization of Candida auris, improving the classification and management of new outbreaks, and helping epidemiologists prevent further outbreaks.

You can now view the most comprehensive dataset of 100 diverse Acinetobacter baumannii genomes directly on Solu!

Follow a genomic investigation into a Shiga toxin producing E.coli outbreak

The emerging fungal pathogen Candida auris is a growing public health threat due to its fast spread, multidrug-resistance, high transmissibility, and high mortality rates. We created a free web application called candida.app for fast and easy genomic characterization of C.auris isolates.

Salmonella Typhi is a bacterial pathogen that causes typhoid fever, a serious illness affecting millions of people worldwide. In this case study, we will explore the use of the Solu platform to investigate a Salmonella Typhi outbreak and analyze the genomic data associated with it.

Candida auris is an emerging health threat, and better genomic analysis tool are needed for its surveillance. Candida.app is a free, user-friendly tool for genomic analysis of C. auris isolates. This validation study shows that Solu and candida.app are accurate for genomıc characterization of Candida auris.

The first real-time database of bacteria and their evolution.